Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
9.45
-0.39 (-4.01%)
Jul 15, 2025, 4:00 PM - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $115.42 million as of July 16, 2025. Its market cap has increased by 559.55% in one year.
Market Cap
115.42M
Enterprise Value
69.56M
1-Year Change
559.55%
Ranking
Category
Stock Price
$9.45
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $115.42M, a decrease of -45.94%. That is a compound annual growth rate of -7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 64.70M | 94.88% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.73B |
| Johnson & Johnson | 373.83B |
| AbbVie | 329.22B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 265.11B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 229.08B |
| AstraZeneca | 222.35B |